JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263412

Human USP54 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

USP54 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 107 bp insertion in exon5.

View Alternative Names

C10orf29, FLJ37318, Inactive ubiquitin carboxyl-terminal hydrolase 54, bA137L10.3, bA137L10.4, nactive ubiquitin-specific peptidase 54

1 Images
Sanger Sequencing - Human USP54 knockout HeLa cell lysate (AB263412)
  • Sanger seq

Unknown

Sanger Sequencing - Human USP54 knockout HeLa cell lysate (AB263412)

Homozygous : 107 bp insertion in exon5

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 107 bp insertion in exon5.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263412-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human USP54 knockout HeLa cell lysate", "number":"AB263412-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263412-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
USP54
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

USP54 also known as Ubiquitin-Specific Protease 54 is a deubiquitinating enzyme. It is part of the large family of proteases that removes ubiquitin from proteins marked for degradation therefore regulating their stability. The molecular weight of USP54 is approximately 192 kDa. Expression of USP54 occurs in a range of tissues with higher levels seen in some brain areas and liver. It has widespread but varied activity depending on cellular needs and conditions.
Biological function summary

USP54 plays a role in modulating protein turnover and recycling through its deubiquitinating activity. This regulation helps cells maintain balance in protein levels and activity. Unlike some other deubiquitinating enzymes USP54 is not known to be a component of a larger protein complex. However it shares functional similarities with other enzymes in the ubiquitin-proteasome system which orchestrates the targeted degradation of proteins to control cellular processes.

Pathways

USP54 engages in the ubiquitin-proteasome pathway a critical pathway for protein degradation. This pathway ensures timely removal of misfolded or damaged proteins. USP54 may interact with proteins involved in this pathway to fine-tune the degradation process. Within the context of cellular regulatory networks USP54 may also have connections with signaling pathways where regulation of protein levels impacts signaling cascades. For instance proteins like UBE2D3 and UBC are ubiquitin-conjugating enzymes that might be related through shared pathway dynamics.

USP54 exhibits links to certain cancers and neurological disorders. Its role in protein regulation suggests impacts on cancer through protein stability potentially affecting cell growth and survival. Aberrant expression of USP54 may lead to altered degradation of oncogenic proteins. In neurological disorders USP54's higher expression in brain areas might suggest involvement in processes important for neural maintenance or development. The regulatory actions of USP54 might relate to proteins like p53 a known tumor suppressor protein by influencing its degradation and stability in cancer pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com